About: Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • Motor complications in Parkinson's disease (PD) result from the short half-life and irregular plasma fluctuations of oral levodopa. When strategies of providing more continuous dopaminergic stimulation by adjusting oral medication fail, patients may be candidates for one of three device-aided therapies: deep brain stimulation (DBS), continuous subcutaneous apomorphine infusion, or continuous duodenal/jejunal levodopa/carbidopa pump infusion (DLI). These therapies differ in their invasiveness, side-effect profile, and the need for nursing care. So far, very few comparative studies have evaluated the efficacy of the three device-aided therapies for specific motor problems in advanced PD. As a result, neurologists currently lack guidance as to which therapy could be most appropriate for a particular PD patient. A group of experts knowledgeable in all three therapies reviewed the currently available literature for each treatment and identified variables of clinical relevance for choosing one of the three options such as type of motor problems, age, and cognitive and psychiatric status. For each scenario, pragmatic and (if available) evidence-based recommendations are provided as to which patients could be candidates for either DBS, DLI, or subcutaneous apomorphine.
  • Motor complications in Parkinson's disease (PD) result from the short half-life and irregular plasma fluctuations of oral levodopa. When strategies of providing more continuous dopaminergic stimulation by adjusting oral medication fail, patients may be candidates for one of three device-aided therapies: deep brain stimulation (DBS), continuous subcutaneous apomorphine infusion, or continuous duodenal/jejunal levodopa/carbidopa pump infusion (DLI). These therapies differ in their invasiveness, side-effect profile, and the need for nursing care. So far, very few comparative studies have evaluated the efficacy of the three device-aided therapies for specific motor problems in advanced PD. As a result, neurologists currently lack guidance as to which therapy could be most appropriate for a particular PD patient. A group of experts knowledgeable in all three therapies reviewed the currently available literature for each treatment and identified variables of clinical relevance for choosing one of the three options such as type of motor problems, age, and cognitive and psychiatric status. For each scenario, pragmatic and (if available) evidence-based recommendations are provided as to which patients could be candidates for either DBS, DLI, or subcutaneous apomorphine. (en)
Title
  • Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review
  • Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review (en)
skos:prefLabel
  • Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review
  • Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review (en)
skos:notation
  • RIV/00216208:11110/13:10191805!RIV14-MSM-11110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I
http://linked.open...iv/cisloPeriodika
  • 11
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 104514
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11110/13:10191805
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Parkinson's disease; Duodenal levodopa infusion; Deep brain stimulation; Apomorphine (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • DE - Spolková republika Německo
http://linked.open...ontrolniKodProRIV
  • [F490B2610CFE]
http://linked.open...i/riv/nazevZdroje
  • Journal of Neurology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 260
http://linked.open...iv/tvurceVysledku
  • Poewe, Werner
  • Růžička, Evžen
  • Oertel, Wolfgang
  • Albanese, Alberto
  • Antonini, Angelo
  • Chaudhuri, K. Ray
  • Clarke, Carl E.
  • Deuschl, Gunther
  • Eggert, Karla
  • Houeto, Jean-Luc
  • Kulisevsky, Jaime
  • Nyholm, Dag
  • Odin, Per
  • Ostergaard, Karen
  • Pollak, Pierre
  • Rabey, Jose Martin
  • Rascol, Olivier
  • Samuel, Michael
  • Speelman, Hans
  • Sydow, Olof
  • Valldeoriola, Francesc
  • Volkmann, Jens
  • de Bie, Rob M. A.
  • van der Linden, Chris
http://linked.open...ain/vavai/riv/wos
  • 000326400800001
issn
  • 0340-5354
number of pages
http://bibframe.org/vocab/doi
  • 10.1007/s00415-012-6798-6
http://localhost/t...ganizacniJednotka
  • 11110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software